This Integrative Pharmacological Sciences Training Program (IPSTP) is designed for 2nd and 3rd year Ph.D. students pursuing dissertation research projects in the pharmacological sciences. Trainees and training faculty (n=36) are drawn from 4 Ph.D. programs (Biochemistry &Molecular Biology, Cell &Molecular Biology, Neuroscience and Pharmacology &Toxicology). The unique focus of the IPSTP is training with in vivo pharmacological approaches and concepts. The research expertise of IPSTP training faculty is clustered into three overlapping themes: 1) cell growth, differentiation, injury and repair;2) intra and intercellular signaling and, 3) integrative pharmacology and physiology. Funds are requested to support 3 students in year 1 and 6 students in years 2-5 (each student receives 2 years of support). The training program will be administered by a Program Director (Galligan) and an Executive Committee composed of a representative of each program and a student trainee. The program is also guided by an Internal Advisory Committee composed of the Chairs or Directors of the participating Ph.D. programs. There are 7 core elements to the training plan: 1) a research project whose results lead to a Ph.D. dissertation and a contribution to knowledge in the pharmacological sciences;2) a two week short course in pharmacological methods (""""""""Boot camp"""""""");3) a three course curriculum in pharmacology and biostatistics;4) a weekly Communications Skills and Professional Development Workshop (trainee participation is required during the two years of program support and for two years after support has ended);5) a mentored teaching experience;6) participation in a quantitative systems biology workshop and;7) participation in an annual program retreat. Trainees are also required to attend the Responsible Conduct of Research (RCR) workshop series provided by the Graduate School and program specific RCR activities. Supplemental activities that are available to trainees include: 1) opportunities to participate in development and delivery of online classes;2) participation in an internship (4-6 week) in an on-campus In Vivo Pharmacology facility which functions as a contract research organization. Trainees would be exposed to issues related to contract work (Good Laboratory Practice protocols, budget and contract development, data security, delivering outcomes on schedule). The IPSTP has developed a comprehensive plan to recruit highly qualified students including under-represented minority students. The IPSTP will provide trainees with excellent research and professional training and will prepare them for research careers in academia, industry and government.

Public Health Relevance

The proposed training program will prepare students for leadership careers in pharmacological research. The trainees completing this program will make important contributions to our understanding of the causes and treatments of human illness.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Institutional National Research Service Award (T32)
Project #
5T32GM092715-03
Application #
8514635
Study Section
National Institute of General Medical Sciences Initial Review Group (BRT)
Program Officer
Okita, Richard T
Project Start
2011-07-01
Project End
2016-06-30
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
3
Fiscal Year
2013
Total Cost
$178,618
Indirect Cost
$8,490
Name
Michigan State University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
193247145
City
East Lansing
State
MI
Country
United States
Zip Code
48824
Zhang, Di; Rennhack, Jonathan; Andrechek, Eran R et al. (2018) Identification of an Unfavorable Immune Signature in Advanced Lung Tumors from Nrf2-Deficient Mice. Antioxid Redox Signal 29:1535-1552
Shaw, Vincent S; Mohammadiarani, Hossein; Vashisth, Harish et al. (2018) Differential Protein Dynamics of Regulators of G-Protein Signaling: Role in Specificity of Small-Molecule Inhibitors. J Am Chem Soc 140:3454-3460
El-Ayache, Nadine; Galligan, James J (2018) 5-HT3 receptor signaling in serotonin transporter knockout rats: a female sex specific animal model of visceral hypersensitivity. Am J Physiol Gastrointest Liver Physiol :
Njomen, Evert; Osmulski, Pawel A; Jones, Corey L et al. (2018) Small Molecule Modulation of Proteasome Assembly. Biochemistry 57:4214-4224
Li, Jinpeng; Bach, Anthony; Crawford, Robert B et al. (2018) CLARITY-BPA: Effects of chronic Bisphenol A exposure on the immune system: Part 1 - Quantification of the relative number and proportion of leukocyte populations in the spleen and thymus. Toxicology 396-397:46-53
Pant, Asmita; Kopec, Anna K; Baker, Kevin S et al. (2018) Plasminogen Activator Inhibitor-1 Reduces Tissue-Type Plasminogen Activator-Dependent Fibrinolysis and Intrahepatic Hemorrhage in Experimental Acetaminophen Overdose. Am J Pathol 188:1204-1212
Zagorski, Joseph W; Turley, Alexandra E; Freeborn, Robert A et al. (2018) Differential effects of the Nrf2 activators tBHQ and CDDO-Im on the early events of T cell activation. Biochem Pharmacol 147:67-76
Zhang, Di; Leal, Ana S; Carapellucci, Sarah et al. (2018) Chemoprevention of Preclinical Breast and Lung Cancer with the Bromodomain Inhibitor I-BET 762. Cancer Prev Res (Phila) 11:143-156
Fader, Kelly A; Nault, Rance; Raehtz, Sandi et al. (2018) 2,3,7,8-Tetrachlorodibenzo-p-dioxin dose-dependently increases bone mass and decreases marrow adiposity in juvenile mice. Toxicol Appl Pharmacol 348:85-98
Fader, K A; Nault, R; Kirby, M P et al. (2018) Corrigendum to ""Convergence of hepcidin deficiency, systemic iron overloading, heme accumulation, and REV-ERB?/? activation in aryl hydrocarbon receptor-elicited hepatotoxicity"" [Toxicol. Appl. Pharmacol. 321 (2017) 1-17]. Toxicol Appl Pharmacol 344:74

Showing the most recent 10 out of 56 publications